Marinus Pharmaceuticals is a company of dedicated individuals committed to developing effective treatments for neurological disorders. Nearly all of the Marinus management team works closely with or supports the efforts of a number of non-profit epilepsy advocacy groups. Staff involvement includes sitting on the boards of various epilepsy foundations as well as attending and participating in epilepsy conferences around the world.

Marinus is excited to advance ganaxolone in clinical trials to further epilepsy research and to share the results with the epilepsy community once they become available.

Below are additional resources for general information on epilepsy and seizures:

Here are additional resources for patients:

General Epilepsy Information Resources:

The Centers for Disease Control and Prevention
» http://www.cdc.gov/Epilepsy

National Institute of Neurological Disorders and Stroke ‘
» http://www.ninds.nih.gov/disorders/epilepsy

The Epilepsy Project
» http://www.epilepsy.org

Patient Resources:

The Epilepsy Foundation of America
» http://www.epilepsyfoundation.org

CURE
» http://www.cureepilepsy.org

International Bureau of Epilepsy
» http://www.ibe-epilepsy.org/

The Epilepsy Project
» http://www.epilepsy.com